Gunma, Japan

Tatsuo Nakajima

This inventor holds 1 USPTO granted patent. Top assignee: Kirin Brewery Company, Limited. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuo Nakajima. Retrieved from https://idiyas.com/inventor/tatsuo-nakajima-ccvkf95o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tatsuo Nakajima: A Pioneer in Pharmaceutical Chemistry

Introduction: Tatsuo Nakajima, hailing from Gunma, Japan, is an accomplished inventor with a focus on pharmaceutical chemistry. With one significant patent to his name, Nakajima continues to contribute to the field through his association with the esteemed Kirin Brewery Company, Limited.

Latest Patents: Nakajima's notable patent involves the development of diphenylmethyl piperazine derivatives. This innovation showcases his expertise in creating compounds that may hold potential therapeutic applications, marking a step forward in pharmaceutical advancements.

Career Highlights: Throughout his career at Kirin Brewery Company, Limited, Tatsuo Nakajima has demonstrated a commitment to innovation in the pharmaceutical sector. His work not only highlights his individual contributions but also reflects the company's dedication to research and development.

Collaborations: Collaborating with talented individuals such as Noboru Kaneko and Makoto Takeishi, Nakajima has enhanced the creative output and innovation pipeline at Kirin Brewery. This teamwork is integral to fostering an environment where groundbreaking inventions can flourish.

Conclusion: Tatsuo Nakajima’s journey as an inventor exemplifies the significant impact that dedicated professionals can have in the realm of pharmaceuticals. With his innovative work on diphenylmethyl piperazine derivatives and collaboration with skilled colleagues, Nakajima has positioned himself as a valuable contributor to advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…